Latest News about GSK
Recent news which mentions GSK
From Benzinga
GSK's Recently Approved Vaccine Offers Long-Term Protection Against RSV in Older Adults, New Data Reveals
June 21, 2023
Tickers
GSK
From Benzinga
Sanofi Stock Is Trading Higher Today - Here's Why
June 20, 2023
From Benzinga
3 Undervalued Consumer Stocks to Buy in June
June 20, 2023
From InvestorPlace
3 Gene Testing Stocks to Buy Before They Take Off
June 17, 2023
From InvestorPlace
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
June 16, 2023
From Motley Fool
From Benzinga
FDA Pushes Review Time For GSK's Blood Cancer Therapy Added Via Sierra Oncology Acquisition
June 16, 2023
Tickers
GSK
From Benzinga
From Benzinga
GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults
June 07, 2023
From Benzinga
From Benzinga
FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades
June 06, 2023
Tickers
GSK
From Benzinga
From MarketWatch
From MarketWatch
From Benzinga
From Benzinga
From MarketWatch
From Motley Fool
From Benzinga
From InvestorPlace
GSK's Meningitis Vaccine Candidate: Crushing Clinical Trials or Just Playing Catch-up with Bexsero and Menveo?
May 12, 2023
Tickers
GSK
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
May 08, 2023
From Benzinga
From Benzinga
KVUE Stock: Should You Buy Into the Kenvue IPO?
May 03, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.